- Home
- UCL vs VTGN Comparison
UCL vs VTGN Comparison
Compare UCL & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCL
- VTGN
- Stock Information
- Founded
- UCL 2014
- VTGN 1998
- Country
- UCL Hong Kong
- VTGN United States
- Employees
- UCL N/A
- VTGN N/A
- Industry
- UCL Telecommunications Equipment
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- UCL Consumer Discretionary
- VTGN Health Care
- Exchange
- UCL Nasdaq
- VTGN Nasdaq
- Market Cap
- UCL 70.6M
- VTGN 59.8M
- IPO Year
- UCL 2020
- VTGN N/A
- Fundamental
- Price
- UCL $2.56
- VTGN $3.08
- Analyst Decision
- UCL
- VTGN
- Analyst Count
- UCL 0
- VTGN 0
- Target Price
- UCL N/A
- VTGN N/A
- AVG Volume (30 Days)
- UCL 115.4K
- VTGN 405.3K
- Earning Date
- UCL 08-13-2025
- VTGN 08-12-2025
- Dividend Yield
- UCL N/A
- VTGN N/A
- EPS Growth
- UCL N/A
- VTGN N/A
- EPS
- UCL 0.09
- VTGN N/A
- Revenue
- UCL $92,256,000.00
- VTGN $486,000.00
- Revenue This Year
- UCL $6.09
- VTGN $23.83
- Revenue Next Year
- UCL $7.01
- VTGN $660.39
- P/E Ratio
- UCL $27.44
- VTGN N/A
- Revenue Growth
- UCL 7.65
- VTGN N/A
- 52 Week Low
- UCL $0.80
- VTGN $1.90
- 52 Week High
- UCL $3.30
- VTGN $3.79
- Technical
- Relative Strength Index (RSI)
- UCL 65.68
- VTGN 75.81
- Support Level
- UCL $1.82
- VTGN $2.25
- Resistance Level
- UCL $2.99
- VTGN $2.83
- Average True Range (ATR)
- UCL 0.24
- VTGN 0.21
- MACD
- UCL 0.04
- VTGN 0.07
- Stochastic Oscillator
- UCL 63.87
- VTGN 84.16
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.